Acorda Therapeutics, Inc. EBITDA 2010-2024 | ACORQ
Acorda Therapeutics, Inc. ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Acorda Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $37 |
| 2022 | $14 |
| 2021 | $-29 |
| 2020 | $-20 |
| 2019 | $15 |
| 2018 | $64 |
| 2017 | $99 |
| 2016 | $-4 |
| 2015 | $61 |
| 2014 | $53 |
| 2013 | $40 |
| 2012 | $35 |
| 2011 | $47 |
| 2010 | $0 |
| 2009 | $-73 |
| Acorda Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-13 |
| 2023-12-31 | $17 |
| 2023-09-30 | $10 |
| 2023-06-30 | $9 |
| 2023-03-31 | $1 |
| 2022-12-31 | $13 |
| 2022-09-30 | $7 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-4 |
| 2021-12-31 | $1 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-63 |
| 2020-09-30 | $30 |
| 2020-06-30 | $5 |
| 2020-03-31 | $8 |
| 2019-12-31 | $305 |
| 2019-09-30 | $-246 |
| 2019-06-30 | $-10 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-44 |
| 2018-09-30 | $34 |
| 2018-06-30 | $66 |
| 2018-03-31 | $8 |
| 2017-12-31 | $88 |
| 2017-09-30 | $6 |
| 2017-06-30 | $13 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $9 |
| 2016-09-30 | $3 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $-11 |
| 2015-12-31 | $11 |
| 2015-09-30 | $32 |
| 2015-06-30 | $12 |
| 2015-03-31 | $5 |
| 2014-12-31 | $7 |
| 2014-09-30 | $26 |
| 2014-06-30 | $14 |
| 2014-03-31 | $6 |
| 2013-12-31 | $16 |
| 2013-09-30 | $14 |
| 2013-06-30 | $11 |
| 2013-03-31 | $-0 |
| 2012-12-31 | $4 |
| 2012-09-30 | $12 |
| 2012-06-30 | $7 |
| 2012-03-31 | $11 |
| 2011-12-31 | $3 |
| 2011-09-30 | $36 |
| 2011-06-30 | $4 |
| 2011-03-31 | $3 |
| 2010-12-31 | $7 |
| 2010-09-30 | $15 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-18 |
| 2009-12-31 | $-20 |
| 2009-09-30 | $-17 |
| 2009-06-30 | $-20 |
| 2009-03-31 | $-17 |
